Oil prices rally after Trump signals ceasefire with Iran has collapsed
Oil prices surged on Wednesday after US President Donald Trump said the ceasefire between the United States and Iran was over, reigniting concerns
Economy
Economy
Dow falls 500 points as Trump’s Iran remarks send oil prices higher
US stocks opened lower on Wednesday after President Donald Trump said an interim agreement aimed at ending the conflict with Iran was “over,”
Economy
Why is Cash Cat price up 1400% today and how high can it climb?
Cash Cat (CASHCAT) has surged by more than 1,400% in the past 24 hours, making it one of the best-performing cryptocurrencies in the
Economy
Gold struggles as inflation fears from rising oil prices offset demand
Spot gold and silver traded lower ahead of the market open on Wednesday as renewed tensions between the United States and Iran lifted
Economy
Celestica stock is up 125% in 12 months: more upside ahead?
Celestica stock has done well in the past few years, helped by the ongoing artificial intelligence (AI) boom. Its US stock has jumped
Economy
Plug Power stock sinks even as turnaround story builds, short interest hits 27.4%
Plug Power stock extended its sharp sell-off this week, falling to its lowest level since April 2. The shares have plunged 45% from
Gold
Rivian stock has flagged an inverted H&S pattern: will the rally continue?
Rivian stock is doing well this month and beating its top rivals like Lucid and Tesla, helped by its strong vehicle delivery numbers.
Gold
Cheap, capable, and controversial: why US companies cannot resist Chinese AI models
Artificial intelligence adoption accelerated sharply across enterprises in 2026, but soaring usage costs are prompting many businesses to rethink their technology choices. This
Gold
Here’s the key risk facing the Palo Alto Networks stock today
Palo Alto Networks stock continues its strong uptrend this week and is now hovering at its all-time high. PANW jumped by 156% from
Gold
Crinetics stocks surge after Vertex agrees to $10B cash buyout
Crinetics Pharmaceuticals shares surged after Vertex Pharmaceuticals announced an agreement to acquire the endocrinology-focused biotech companyin a deal valued at approximately $10 billion.